Physician profile
Divya Menon
NPI 1730327834
$1,212.65
in general payments reported to CMS, 2019-2025
12 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2022: $130 · 2023: $378 · 2024: $339 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $263.38 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $251.62 | 2019-2022 | |
| Abbott Laboratories | $171.13 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $156.93 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $131.00 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $78.55 | 2019-2022 | |
| Davol INC. | $42.21 | 2025 | Arista |
| Impulse Dynamics (USA) INC. | $42.14 | 2024 | Optimizer |
| Scpharmaceuticals INC. | $34.88 | 2023-2024 | |
| Amgen INC. | $14.91 | 2019 | |
| Amarin Pharma, INC. | $14.11 | 2019 | |
| Gilead Sciences, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Menon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.